ADLOID 11.25MG

Adloid 11.25 mg 3 Months Depot Injection 1’s is classified as a gonadotropin-releasing hormone (GnRH) agonist, primarily utilized for the treatment of prostate cancer and endometriosis. It is also indicated for the management of precocious puberty in children. Furthermore, Adloid 11.25 mg 3 Months Depot Injection 1’s is prescribed alongside other medications to address anaemia resulting from uterine fibroids.

This injection contains Leuprolide acetate, a synthetic hormone that mimics the action of GnRH, which is produced by the hypothalamus in the brain. Its mechanism involves suppressing the production of natural male hormone testosterone in men and oestrogen in women. By reducing hormone levels, it can slow down the growth of cancer cells in prostate cancer and assist in the treatment of endometriosis.

Administration of Adloid 11.25 mg 3 Months Depot Injection 1’s will be carried out by a qualified healthcare professional. Common side effects associated with this injection include hot flashes, reduced sexual desire, dizziness, headaches, nausea, vomiting, diarrhea, upset stomach, and reactions at the injection site. These side effects may not be experienced by everyone and can vary from person to person. If you encounter any side effects that are difficult to manage, it is advisable to consult your physician.

It is important to avoid using Adloid 11.25 mg 3 Months Depot Injection 1’s if you are pregnant or breastfeeding. Both men and women receiving this treatment should employ effective contraception. Since Adloid 11.25 mg 3 Months Depot Injection 1’s may impact fertility, it is essential to discuss any future family planning with your doctor. This medication is not recommended for children under the age of two. Additionally, Adloid 11.25 mg 3 Months Depot Injection 1’s may induce dizziness, so it is advised to drive only when you feel fully alert.